SE8803087L - Ett nytt saett foer behandling av erektil dysfunktion - Google Patents
Ett nytt saett foer behandling av erektil dysfunktionInfo
- Publication number
- SE8803087L SE8803087L SE8803087A SE8803087A SE8803087L SE 8803087 L SE8803087 L SE 8803087L SE 8803087 A SE8803087 A SE 8803087A SE 8803087 A SE8803087 A SE 8803087A SE 8803087 L SE8803087 L SE 8803087L
- Authority
- SE
- Sweden
- Prior art keywords
- dysfunction
- erect
- treatment
- new set
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803087A SE463851B (sv) | 1988-09-02 | 1988-09-02 | Komposition foer behandling av erektil dysfunktion via uretra |
IE268089A IE62587B1 (en) | 1988-09-02 | 1989-08-21 | Composition for the treatment of erectile dysfunction |
NZ230400A NZ230400A (en) | 1988-09-02 | 1989-08-22 | Phentolamine and hydrophilic vehicle for use in treating erectile dysfunction |
ES89850282T ES2055677T5 (es) | 1988-09-02 | 1989-08-31 | Composicion para el tratamiento de la disfuncion erectil. |
ZA896681A ZA896681B (en) | 1988-09-02 | 1989-08-31 | A composition for the treatment of erectile dysfunction |
EP89850282A EP0357581B2 (en) | 1988-09-02 | 1989-08-31 | Composition for the treatment of erectile dysfunction |
AT89909891T ATE91886T1 (de) | 1988-09-02 | 1989-09-01 | Praeparat zur behandlung von erektionsstoerungen. |
DE68907909T DE68907909T3 (de) | 1988-09-02 | 1989-09-01 | Präparat zur behandlung von erektionsstörungen. |
EP89909891A EP0432199B2 (en) | 1988-09-02 | 1989-09-01 | Composition for the treatment of erectile dysfunction |
CA000610172A CA1335346C (en) | 1988-09-02 | 1989-09-01 | Method of treating erectile dysfunction |
PCT/SE1989/000462 WO1990002545A1 (en) | 1988-09-02 | 1989-09-01 | Composition for the treatment of erectile dysfunction |
JP1509519A JPH0791199B2 (ja) | 1988-09-02 | 1989-09-01 | ***機能障害の治療用組成物 |
AU41994/89A AU638414B2 (en) | 1988-09-02 | 1989-09-01 | Composition for the treatment of erectile dysfunction |
FI910976A FI102454B1 (sv) | 1988-09-02 | 1991-02-27 | Förfarande för framställning av en komposition för behandling av erektil funktionsstörning |
DK199100364A DK175560B1 (da) | 1988-09-02 | 1991-03-01 | Præparat til behandling af erektiv dysfunktion |
NO910828A NO301046B1 (no) | 1988-09-02 | 1991-03-01 | Fremgangsmåte for fremstilling av preparat for behandling av erektil funksjonssvikt |
GR90300093T GR900300093T1 (en) | 1988-09-02 | 1991-09-27 | Composition for the treatment of erectile dysfunction |
US08/481,609 US5942512A (en) | 1988-09-02 | 1995-06-07 | Method and composition for treating erectile dysfunction |
US08/484,546 US5843961A (en) | 1988-09-02 | 1995-06-07 | Method and composition for treating erectile dysfunction |
US08/485,041 US5886039A (en) | 1988-09-02 | 1995-06-07 | Method and composition for treating erectile dysfunction |
US08/478,982 US5849803A (en) | 1988-09-02 | 1995-06-07 | Method of treating erectile dysfunction with nitroglycerine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803087A SE463851B (sv) | 1988-09-02 | 1988-09-02 | Komposition foer behandling av erektil dysfunktion via uretra |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8803087D0 SE8803087D0 (sv) | 1988-09-02 |
SE8803087L true SE8803087L (sv) | 1990-03-03 |
SE463851B SE463851B (sv) | 1991-02-04 |
Family
ID=20373202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8803087A SE463851B (sv) | 1988-09-02 | 1988-09-02 | Komposition foer behandling av erektil dysfunktion via uretra |
Country Status (16)
Country | Link |
---|---|
US (4) | US5843961A (sv) |
EP (2) | EP0357581B2 (sv) |
JP (1) | JPH0791199B2 (sv) |
AU (1) | AU638414B2 (sv) |
CA (1) | CA1335346C (sv) |
DE (1) | DE68907909T3 (sv) |
DK (1) | DK175560B1 (sv) |
ES (1) | ES2055677T5 (sv) |
FI (1) | FI102454B1 (sv) |
GR (1) | GR900300093T1 (sv) |
IE (1) | IE62587B1 (sv) |
NO (1) | NO301046B1 (sv) |
NZ (1) | NZ230400A (sv) |
SE (1) | SE463851B (sv) |
WO (1) | WO1990002545A1 (sv) |
ZA (1) | ZA896681B (sv) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236904A (en) * | 1989-09-18 | 1993-08-17 | Senetek, Plc | Erection-inducing methods and compositions |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
AU655420B2 (en) * | 1990-04-25 | 1994-12-22 | Vivus, Inc. | Treatment of erectile dysfunction |
AU2300092A (en) * | 1991-07-03 | 1993-02-11 | Nathan E. Scott | Prostaglandin e2 treatment of impotence |
WO1999030718A2 (en) * | 1997-12-18 | 1999-06-24 | Nathan Earl Scott | PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL |
US5981593A (en) * | 1991-07-03 | 1999-11-09 | Scott; Nathan Earl | Prostaglandin E2 treatment of impotence |
US5962528A (en) * | 1991-07-03 | 1999-10-05 | Scott; Nathan Earl | Prostaglandin E2 /F2α combination for treating impotence |
US6291528B1 (en) | 1991-07-03 | 2001-09-18 | Nathan Earl Scott | Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal |
US5503973A (en) * | 1992-05-29 | 1996-04-02 | The Regents Of The University Of California | Method for inhibition of viral morphogenesis |
US20030181355A1 (en) * | 1992-05-29 | 2003-09-25 | Glenn Jeffrey S. | Method for inhibition of viral infection |
BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
US5773457A (en) * | 1995-02-15 | 1998-06-30 | Cesar Roberto Dias Nahoum | Compositions |
US5910316A (en) | 1992-08-24 | 1999-06-08 | The United States Of America, As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents to treat impotency |
US5698589A (en) * | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
US5565466A (en) * | 1993-08-13 | 1996-10-15 | Zonagen, Inc. | Methods for modulating the human sexual response |
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
NZ305560A (en) * | 1995-03-14 | 1998-11-25 | Vivus Inc | Method for preventing erectile dysfunction by administering vasoactive agent, particularly a prostaglandin, kit therefor |
US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
US5718917A (en) * | 1995-12-15 | 1998-02-17 | Harvard Scientific Corporation | PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
US5994294A (en) * | 1996-02-02 | 1999-11-30 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US6294517B1 (en) | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
US6323211B1 (en) | 1996-02-02 | 2001-11-27 | Nitromed, Inc. | Compositions and methods for treating sexual dysfunctions |
US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US6469065B1 (en) | 1996-02-02 | 2002-10-22 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use |
GB9608408D0 (en) * | 1996-04-23 | 1996-06-26 | Adams Michael A | Treatment of erectile dysfunction |
IT1292377B1 (it) * | 1997-06-19 | 1999-02-08 | Nicox Sa | Composizioni farmaceutiche a base di prostaglandine |
IT1292426B1 (it) | 1997-06-27 | 1999-02-08 | Nicox Sa | Sali nitrati di ace-inibitori |
US6399618B1 (en) | 1997-07-09 | 2002-06-04 | Cardiome Pharma Corp | Compositions and methods for modulating sexual activity |
US6103765A (en) * | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
KR20010021625A (ko) | 1997-07-09 | 2001-03-15 | 추후보정 | 개선된 남성발기 기능장애 치료방법 및 그 조성물 |
US5954688A (en) * | 1997-08-26 | 1999-09-21 | Queen's University At Kingston | Everting toroid device for delivering a drug into a body cavity |
US6200288B1 (en) | 1997-08-26 | 2001-03-13 | Queen's University At Kingston | Everting toroid device for insertion into a body cavity |
US5925629A (en) * | 1997-10-28 | 1999-07-20 | Vivus, Incorporated | Transurethral administration of androgenic agents for the treatment of erectile dysfunction |
US5919474A (en) * | 1997-10-28 | 1999-07-06 | Vivus, Inc. | Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
WO1999047923A2 (en) | 1998-03-20 | 1999-09-23 | The Rockefeller University | Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
US6194433B1 (en) | 1998-10-05 | 2001-02-27 | Neal R. Cutler | Sexual dysfunction in females |
US6187790B1 (en) | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
US6110489A (en) * | 1998-05-01 | 2000-08-29 | Cutler; Neal R. | Use of quinolines and quinolones to treat male erectile dysfunction |
US6426084B1 (en) | 2000-06-19 | 2002-07-30 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6132753A (en) * | 1998-05-01 | 2000-10-17 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6132757A (en) | 1998-05-01 | 2000-10-17 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6365590B1 (en) | 1998-05-26 | 2002-04-02 | Saint Louis University | Compounds, compositions and methods for treating erectile dysfunction |
US6124461A (en) * | 1998-05-26 | 2000-09-26 | Saint Louis University, Health Services Center, Research Administration | Compounds, compositions, and methods for treating erectile dysfunction |
US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
US6482426B1 (en) | 1998-09-17 | 2002-11-19 | Zonagen, Inc. | Compositions for the treatment of male erectile dysfunction |
WO2000032195A1 (fr) * | 1998-12-02 | 2000-06-08 | Mochida Pharmaceutical Co., Ltd. | Preparations destinees a etre administrees par voie uretrale |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
AU3713600A (en) | 1999-03-01 | 2000-09-21 | Nitromed, Inc. | Nitrosated and nitrosylated prostaglandins, compositions and metods of use |
AU4663100A (en) | 1999-04-30 | 2000-11-17 | Lilly Icos Llc | Treatment of female arousal disorder |
US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
WO2004028444A2 (en) * | 1999-06-02 | 2004-04-08 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
AUPQ105799A0 (en) | 1999-06-18 | 1999-07-08 | Victor Chang Cardiac Research Institute, The | Cell growth inhibition |
US6303135B1 (en) | 1999-07-08 | 2001-10-16 | Neal R. Cutler | Use of quinolines and quinolones to treat male erectile dysfunction |
US6323241B1 (en) | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6693135B2 (en) | 2000-01-10 | 2004-02-17 | Nexmed (Holdings) Incorporated | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US7105571B2 (en) | 2000-01-10 | 2006-09-12 | Nexmed Holdings, Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6471968B1 (en) | 2000-05-12 | 2002-10-29 | Regents Of The University Of Michigan | Multifunctional nanodevice platform |
WO2002007757A2 (en) | 2000-07-21 | 2002-01-31 | Lue Tom F | Prevention and treatment of sexual arousal disorders |
US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
WO2002102385A1 (en) * | 2001-06-14 | 2002-12-27 | Sampad Bhattacharya | Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
US20040142929A1 (en) * | 2001-07-06 | 2004-07-22 | Ramon Merce-Vidal | Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
CN1203055C (zh) | 2001-09-26 | 2005-05-25 | 朱德煦 | 治疗或预防细菌感染的方法和组合物 |
US7041677B2 (en) | 2002-03-01 | 2006-05-09 | R.T. Alamo Ventures I, Llc | Use of monochloroflosequinan in the treatment of sexual dysfunction |
EP2316853A3 (en) * | 2002-03-08 | 2011-10-05 | Shanghai Institutes for Biological Sciences, CAS | Detection and modulation of slit and roundabout (robo) mediated angiogenesis and uses thereof |
JP4660094B2 (ja) | 2002-03-26 | 2011-03-30 | ゼンサン (シャンハイ) サイ−テク. リミテッド | 新生物を治療するためのErbB3に基づく方法および組成物 |
US20030219696A1 (en) * | 2002-05-23 | 2003-11-27 | Moreland Gerald W. | Method and apparatus for preventing backflow in dental saliva evacuators |
WO2003099320A1 (en) | 2002-05-24 | 2003-12-04 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
KR20040043996A (ko) * | 2002-11-20 | 2004-05-27 | 조나겐, 아이엔씨. | 남성 발기부전치료를 위한 개선된 조성물 |
US7517887B2 (en) * | 2003-04-09 | 2009-04-14 | General Atomics | Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
US7196093B2 (en) * | 2003-04-09 | 2007-03-27 | General Atomics | Reversible inhibitors of SAH hydrolase and uses thereof |
US7868011B2 (en) * | 2003-04-09 | 2011-01-11 | General Atomics | Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
CN1869002A (zh) * | 2005-05-27 | 2006-11-29 | 中国科学院上海药物研究所 | 一类非甾体雄激素受体调节剂、其制备方法和用途 |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
US8889635B2 (en) | 2008-09-30 | 2014-11-18 | The Regents Of The University Of Michigan | Dendrimer conjugates |
US9017644B2 (en) | 2008-11-07 | 2015-04-28 | The Regents Of The University Of Michigan | Methods of treating autoimmune disorders and/or inflammatory disorders |
EP2488172A4 (en) | 2009-10-13 | 2014-08-13 | Univ Michigan | DENDRIMER COMPOSITION AND METHOD FOR THEIR SYNTHESIS |
WO2011059586A2 (en) | 2009-10-30 | 2011-05-19 | The Regents Of The University Of Michigan | Multifunctional small molecules |
CA2802526C (en) | 2010-06-13 | 2021-11-16 | Institute Of Biophysics, Chinese Academy Of Sciences | Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof |
WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun (Shanghai)Science & Technology Limited | Compositions and methods for treating heart failure |
WO2013085718A1 (en) | 2011-12-08 | 2013-06-13 | The Regents Of The University Of Michigan | Multifunctional small molecules |
CN104508121B (zh) | 2012-07-23 | 2018-01-19 | 中国科学院生物物理研究所 | 体外诱导多能干细胞分化为心室肌细胞的方法 |
RU2650635C2 (ru) | 2012-10-08 | 2018-04-16 | Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. | Композиции и способы лечения сердечной недостаточности у пациентов с диабетом |
BR112015029293A2 (pt) | 2013-05-22 | 2018-04-24 | Zensun Shanghai Science & Tech Ltd | método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero |
CN113289002A (zh) | 2020-02-24 | 2021-08-24 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52156913A (en) * | 1976-06-21 | 1977-12-27 | Toko Yakuhin Kogyo Kk | Production of injectionable medicine |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
CA1188987A (en) * | 1981-03-06 | 1985-06-18 | Masataka Morishita | Preparation having excellent absorption property |
US4746508A (en) * | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
EP0149254A3 (en) * | 1983-12-29 | 1987-01-28 | The Research Foundation Of State University Of New York | Fungicidal polypeptide compositions containing l-histidine |
DE3637157A1 (de) * | 1985-11-01 | 1987-05-21 | Byk Gulden Lomberg Chem Fab | Arzneimittel zur behandlung erektiler dysfunktionen |
EP0266968A3 (en) * | 1986-11-03 | 1988-08-24 | Gérard G. Cohen | Gelled ointment of vasodilating agent |
US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
DE3913954A1 (de) * | 1989-04-27 | 1990-10-31 | Stief Georg | Arzneimittel zur behandlung erektiler dysfunktionen |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
US5583144A (en) * | 1995-02-24 | 1996-12-10 | Kral; John G. | Methods for treating erectile impotence |
-
1988
- 1988-09-02 SE SE8803087A patent/SE463851B/sv not_active IP Right Cessation
-
1989
- 1989-08-21 IE IE268089A patent/IE62587B1/en not_active IP Right Cessation
- 1989-08-22 NZ NZ230400A patent/NZ230400A/xx unknown
- 1989-08-31 EP EP89850282A patent/EP0357581B2/en not_active Expired - Lifetime
- 1989-08-31 ZA ZA896681A patent/ZA896681B/xx unknown
- 1989-08-31 ES ES89850282T patent/ES2055677T5/es not_active Expired - Lifetime
- 1989-09-01 AU AU41994/89A patent/AU638414B2/en not_active Expired
- 1989-09-01 JP JP1509519A patent/JPH0791199B2/ja not_active Expired - Lifetime
- 1989-09-01 WO PCT/SE1989/000462 patent/WO1990002545A1/en active IP Right Grant
- 1989-09-01 CA CA000610172A patent/CA1335346C/en not_active Expired - Lifetime
- 1989-09-01 DE DE68907909T patent/DE68907909T3/de not_active Expired - Lifetime
- 1989-09-01 EP EP89909891A patent/EP0432199B2/en not_active Expired - Lifetime
-
1991
- 1991-02-27 FI FI910976A patent/FI102454B1/sv active
- 1991-03-01 DK DK199100364A patent/DK175560B1/da not_active IP Right Cessation
- 1991-03-01 NO NO910828A patent/NO301046B1/no not_active IP Right Cessation
- 1991-09-27 GR GR90300093T patent/GR900300093T1/el unknown
-
1995
- 1995-06-07 US US08/484,546 patent/US5843961A/en not_active Expired - Lifetime
- 1995-06-07 US US08/485,041 patent/US5886039A/en not_active Expired - Lifetime
- 1995-06-07 US US08/481,609 patent/US5942512A/en not_active Expired - Lifetime
- 1995-06-07 US US08/478,982 patent/US5849803A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8803087L (sv) | Ett nytt saett foer behandling av erektil dysfunktion | |
LV12452A (lv) | Aktivas vielas vaginala ievadisanas sistema | |
CA2055493A1 (en) | Antineoplastic solution and method for treating neoplasms | |
DE69130529T2 (de) | Behandlung von erektionversagen | |
SE8803486D0 (sv) | Dosage form for treating cardiovascular diseases | |
ATE110578T1 (de) | Von hydrogel angetriebene verabreichungsvorrichtung. | |
DE69112895D1 (de) | Pharmazeutische Verbindungen. | |
ATE290836T1 (de) | Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern | |
PT637933E (pt) | Metodo para tratamento de orgaos e tecidos | |
EP0489108A4 (en) | Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists | |
PT97785A (pt) | Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina | |
DE69013797D1 (de) | Gehirnspezifische Zubereitung mit gesteuerter Abgabe. | |
ES2063202T3 (es) | Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida. | |
IT1275816B1 (it) | Composizioni farmaceutiche solide per uso vaginale | |
ES2095578T3 (es) | Composicion para el tratamiento de mastitis y metritis. | |
DE59506374D1 (de) | Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel | |
DE59000613D1 (de) | Pflaster zur transdermalen anwendung. | |
ES2129401T3 (es) | Uso de un compuesto terapeutico para el tratamiento de bronquitis. | |
DE69009765D1 (de) | Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES2054652T3 (es) | Composicion farmaceutica acuosa. | |
EP0539516A4 (sv) | ||
AU5903690A (en) | Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e) azepine-6, 11-dione and derivatives as drugs for use in the treatment of urinary incontinence | |
ES2113870T3 (es) | Utilizacion de n,n'-bis 3-(etilamino)propil-1,7-heptanodiamina y un agente citotoxico. | |
KR927003530A (ko) | 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도 | |
KR930700109A (ko) | 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8803087-9 Format of ref document f/p: F |
|
NUG | Patent has lapsed |